Subscribe
COVID-19 Miniseries Episode 56: Mayo Clinic Q&A – How Messenger RNA Vaccines Work

Mayo Clinic Talks

COVID-19 Miniseries Episode 56: Mayo Clinic Q&A – How Messenger RNA Vaccines Work

This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) The first COVID-19…
December 3, 2020
ADVERTISEMENT
TransferWise

COVID-19 Miniseries Episode 56: Mayo Clinic Q&A – How Messenger RNA Vaccines Work

This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. 

To claim credit visit: https://ce.mayo.edu/covid19podcast 

Guest: Gregory A. Poland, M.D. (@drgregpoland) 

Host: Halena M. Gazelka, M.D. (@hmgazelkamd

The first COVID-19 vaccines to reach the market are likely to be messenger RNA vaccines, or mRNA. According to the Centers for Disease Control and Prevention, mRNA vaccines work by teaching cells in the body how to make a protein that triggers an immune response. Unlike many vaccines that use a weakened or inactivated form of a virus, mRNA vaccines do not use the live virus that causes COVID-19. 

On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, explains how mRNA vaccines work, gives a status update on the pandemic and answers listener questions.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd

ADVERTISEMENT
TransferWise

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.